SCHEMBL27214767

SCHEMBL27214767

CSc1ccc(C#Cc2ccc([Si](C)(C)C)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACACB O00763 2/20 0.42
ALDH1A1 P00352 1/20 0.34
PTGS2 P35354 1/20 0.32
SLC6A4 P31645 4/20 0.31
NOS3 P29474 2/20 0.31
NOS1 P29475 2/20 0.31
GRM5 P41594 2/20 0.31
NR1H2 P55055 1/20 0.31
NR1H3 Q13133 1/20 0.31
APP P05067 1/20 0.31
NISCH Q9Y2I1 1/20 0.31
PLK1 P53350 1/20 0.31
MAOA P21397 1/20 0.31
SLC6A2 P23975 1/20 0.31
SLC6A3 Q01959 1/20 0.31
MAOB P27338 1/20 0.30
AOC3 Q16853 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10300058 0.84 ACACB (0.52) ACACBALDH1A1SLC6A4NOS3NOS1
SCHEMBL20681670 0.84 ACACB (0.52) ACACBALDH1A1SLC6A4NOS3NOS1
SCHEMBL25798906 0.77 ACACB (0.40) ACACBALDH1A1PTGS2SLC6A4NOS3
SCHEMBL456129 0.76 APP (0.57) ALDH1A1GRM5APP
SCHEMBL7569429 0.76 APP (0.57) ACACBALDH1A1PTGS2GRM5APP
SCHEMBL27159386 0.75 ACACB (0.44) ACACBALDH1A1PTGS2SLC6A4NOS3
SCHEMBL7567051 0.74 ACACB (0.45) ACACBALDH1A1PTGS2SLC6A4GRM5
SCHEMBL27159383 0.74 RAB9A (0.47) ACACBALDH1A1GRM5MAOAMAOB
SCHEMBL14996347 0.74 APP (0.52) ACACBALDH1A1PTGS2NOS3NOS1
SCHEMBL27159507 0.73 KIF11 (0.42) ACACBALDH1A1SLC6A4NOS3NOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240151993-A1 ELECTRON WITHDRAWING GROUP (EWG)-CONTAINING ORGANIC MOLECULES FOR IMPROVED OPTICAL PROPERTIES IN AR/VR COMPONENTS META PLATFORMS TECHNOLOGIES, LLC 2024-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240151993-A1 ELECTRON WITHDRAWING GROUP (EWG)-CONTAINING ORGANIC MOLECULES FOR IMPROVED OPTICAL PROPERTIES IN AR/VR COMPONENTS AR, OR10J3, ESRRG ACACB 4258/4885ALDH1A1 2350/4885PTGS2 3341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.